CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 729 participants.
Also called NCT03296540
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 729 participants
- Sponsor
- Registry
-
NCT03296540
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT03296540. Randomized; no masking; primary purpose treatment. Start 2017-11-28 (actual); primary completion 2021-05-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
- Acronym
- CompareCrush
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Prasugrel (Crushed tablets)
- Intervention (Drug)
- Prasugrel (Integral tablets)
- Lead sponsor
- Maasstad Hospital
- Collaborator
- MicroPort Orthopedics Inc.
- Collaborator
- Daiichi Sankyo
- Collaborator
- Research Maatschap Cardiologen Rotterdam Zuid
Record details
- Record id
cardio:ct-nct03296540- Content hash
b625a48e62862f871ce92b348c8637e95878cf4cc7deddc31ada2df65d2c4a88